These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22915799)

  • 21. RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.
    Bernacchi S; Henriet S; Dumas P; Paillart JC; Marquet R
    J Biol Chem; 2007 Sep; 282(36):26361-8. PubMed ID: 17609216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying the antiviral effect of APOBEC3 on HIV-1 infection in humanized mouse model.
    Kurusu T; Kim KS; Koizumi Y; Nakaoka S; Ejima K; Misawa N; Koyanagi Y; Sato K; Iwami S
    J Theor Biol; 2020 Aug; 498():110295. PubMed ID: 32335137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles.
    Wang X; Li X; Ma J; Zhang L; Ma L; Mi Z; Zhou J; Guo F; Kleiman L; Cen S
    Virus Res; 2014 Oct; 191():30-8. PubMed ID: 25038404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.
    Hultquist JF; Lengyel JA; Refsland EW; LaRue RS; Lackey L; Brown WL; Harris RS
    J Virol; 2011 Nov; 85(21):11220-34. PubMed ID: 21835787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.
    Chaipan C; Smith JL; Hu WS; Pathak VK
    J Virol; 2013 Jan; 87(1):444-53. PubMed ID: 23097438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies.
    Mohammadzadeh N; Follack TB; Love RP; Stewart K; Sanche S; Chelico L
    Virology; 2019 Jan; 527():21-31. PubMed ID: 30448640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
    Binka M; Ooms M; Steward M; Simon V
    J Virol; 2012 Jan; 86(1):49-59. PubMed ID: 22013041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional domain organization of human APOBEC3G.
    Gooch BD; Cullen BR
    Virology; 2008 Sep; 379(1):118-24. PubMed ID: 18639915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
    He Z; Zhang W; Chen G; Xu R; Yu XF
    J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.
    Doehle BP; Schäfer A; Wiegand HL; Bogerd HP; Cullen BR
    J Virol; 2005 Jul; 79(13):8201-7. PubMed ID: 15956565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages.
    Burdick R; Smith JL; Chaipan C; Friew Y; Chen J; Venkatachari NJ; Delviks-Frankenberry KA; Hu WS; Pathak VK
    J Virol; 2010 Oct; 84(19):10241-53. PubMed ID: 20668078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H.
    Harari A; Ooms M; Mulder LC; Simon V
    J Virol; 2009 Jan; 83(1):295-303. PubMed ID: 18945781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOBEC3 inhibits DEAD-END function to regulate microRNA activity.
    Ali S; Karki N; Bhattacharya C; Zhu R; MacDuff DA; Stenglein MD; Schumacher AJ; Demorest ZL; Harris RS; Matin A; Aggarwal S
    BMC Mol Biol; 2013 Jul; 14():16. PubMed ID: 23890083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
    Zhang W; Chen G; Niewiadomska AM; Xu R; Yu XF
    PLoS One; 2008; 3(12):e3963. PubMed ID: 19088851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.
    Refsland EW; Stenglein MD; Shindo K; Albin JS; Brown WL; Harris RS
    Nucleic Acids Res; 2010 Jul; 38(13):4274-84. PubMed ID: 20308164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.
    Wang T; Zhang W; Tian C; Liu B; Yu Y; Ding L; Spearman P; Yu XF
    Virology; 2008 Jul; 377(1):71-9. PubMed ID: 18495196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
    Adolph MB; Ara A; Chelico L
    J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.
    Sato K; Takeuchi JS; Misawa N; Izumi T; Kobayashi T; Kimura Y; Iwami S; Takaori-Kondo A; Hu WS; Aihara K; Ito M; An DS; Pathak VK; Koyanagi Y
    PLoS Pathog; 2014 Oct; 10(10):e1004453. PubMed ID: 25330146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.